Cheviot Value Management
GILD icon

Cheviot Value Management’s Gilead Sciences GILD Stock Holding History

Cheviot Value Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$111K Buy
742
+5
+0.7% +$702 0.01% 162
2026
Q2 		$93.1K Buy
737
+5
+0.7% +$659 0.01% 172
2026
Q1 		$102K Buy
732
+4
+0.5% +$560 0.01% 159
2025
Q4 		$102K Buy
728
+5
+0.7% +$608 0.01% 165
2025
Q3 		$85.3K Buy
723
+5
+0.7% +$568 0.01% 187
2025
Q2 		$85.8K Sell
718
-45
-6% -$4.79K 0.01% 168
2025
Q1 		$78.4K Buy
+763
New +$78.7K 0.01% 166

Other funds holding GILD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Cheviot Value Management's GILD Position: Q3 2026 in Review

Cheviot Value Management increased its Gilead Sciences (GILD) stake by 0.68% in Q3 2026, buying an estimated $702 and bringing the position to 742 shares worth $111K. The position accounts for 0.01% of the portfolio, ranked #162.

Cheviot Value Management first reported a position in GILD in Q1 2025 and has held it in 7 quarters since. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Cheviot Value Management held 742 shares of Gilead Sciences worth $111K as of Q3 2026.
  • Cheviot Value Management bought 5 Gilead Sciences shares in Q3 2026, an estimated $702.
  • Gilead Sciences made up 0.01% of Cheviot Value Management's portfolio in Q3 2026, its #162 holding.
  • Cheviot Value Management first reported a position in Gilead Sciences in Q1 2025 and has held it in 7 quarters since.
  • 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Cheviot Value Management's 13F filing for Q3 2026, filed 9 Nov 2026.